In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, VolitionRX Ltd (AMEX: VNRX) closed at $0.46 down -22.65% from its previous closing price of $0.6. In other words, the price has decreased by -$22.65 from its previous closing price. On the day, 2.02 million shares were traded. VNRX stock price reached its highest trading level at $0.51 during the session, while it also had its lowest trading level at $0.46.
Ratios:
For a deeper understanding of VolitionRX Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.35 and its Current Ratio is at 0.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 08, 2025, initiated with a Buy rating and assigned the stock a target price of $2.50.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 12 ’25 when Reynolds Cameron John bought 15,000 shares for $0.66 per share. The transaction valued at 9,885 led to the insider holds 2,624,847 shares of the business.
Innes Guy Archibald bought 78,125 shares of VNRX for $50,000 on Aug 05 ’25. The Director now owns 966,814 shares after completing the transaction at $0.64 per share. On Aug 05 ’25, another insider, Reynolds Cameron John, who serves as the President and CEO of the company, bought 78,125 shares for $0.64 each. As a result, the insider paid 50,000 and bolstered with 2,609,847 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VNRX now has a Market Capitalization of 49935036 and an Enterprise Value of 57340712. For the stock, the TTM Price-to-Sale (P/S) ratio is 37.83. Its current Enterprise Value per Revenue stands at 43.465 whereas that against EBITDA is -2.562.
Stock Price History:
The Beta on a monthly basis for VNRX is 1.28, which has changed by -0.3611111 over the last 52 weeks, in comparison to a change of 0.118204355 over the same period for the S&P500. Over the past 52 weeks, VNRX has reached a high of $0.94, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is -27.38%, while the 200-Day Moving Average is calculated to be -23.38%.
Shares Statistics:
For the past three months, VNRX has traded an average of 199.19K shares per day and 512170 over the past ten days. A total of 103.98M shares are outstanding, with a floating share count of 79.03M. Insiders hold about 26.70% of the company’s shares, while institutions hold 22.32% stake in the company. Shares short for VNRX as of 1759190400 were 335716 with a Short Ratio of 1.69, compared to 1756425600 on 298499. Therefore, it implies a Short% of Shares Outstanding of 335716 and a Short% of Float of 0.43.
Earnings Estimates
The stock of VolitionRX Ltd (VNRX) is currently drawing attention from 5.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.04 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.2 and -$0.25 for the fiscal current year, implying an average EPS of -$0.22. EPS for the following year is -$0.1, with 4.0 analysts recommending between $0.09 and -$0.18.
Revenue Estimates
A total of 4 analysts believe the company’s revenue will be $715.59k this quarter.It ranges from a high estimate of $890k to a low estimate of $508.36k. As of. The current estimate, VolitionRX Ltd’s year-ago sales were $474.52kFor the next quarter, 4 analysts are estimating revenue of $966.11k. There is a high estimate of $1.27M for the next quarter, whereas the lowest estimate is $635.45k.
A total of 4 analysts have provided revenue estimates for VNRX’s current fiscal year. The highest revenue estimate was $2.81M, while the lowest revenue estimate was $1.5M, resulting in an average revenue estimate of $2.17M. In the same quarter a year ago, actual revenue was $1.23MBased on 5 analysts’ estimates, the company’s revenue will be $18.16M in the next fiscal year. The high estimate is $29.26M and the low estimate is $2.56M.
